Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma RINO Bill Cassidy Smoked By Trump-Endorsed Candidate In Louisiana Senate Primary
Senator Bill Cassidy (R-LA) came in third in Louisiana's Republican Senate primary on Saturday - marking the first time in nearly 15 years that a sitting US Senator has lost a primary in a regularly scheduled election. Instead, Trump-endorsed Rep.
Boxer Capital's $18 Million Corvus Pharma Bet Signals Confidence in This Biotech's Next Phase
On May 15, 2026, Boxer Capital Management disclosed a new position in Corvus Pharmaceuticals (CRVS 9.85%), acquiring 1,100,000 shares in the first quarter for an estimated $17.55 million based on quarterly average pricing. According to a May 15…
Vistin Pharma ASA (OB: VISTN) Stock Ex-Dividend Deadline Approaches as Income Investors Weigh Payout Sustainability
Income-focused investors in Vistin Pharma ASA (OB: VISTN) have a narrow window remaining to qualify for the Norwegian pharmaceutical company's next dividend payment. The ex-dividend date falls on May 22, meaning any investor who has not settled a…
U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
Two advocacy groups are demanding the United Kingdom revoke regulations at the heart of a new trade agreement with the U.S. over concerns the deal will allow outsiders to influence official decisions about the cost-effectiveness of medicines. And…
Commerzbank Aktiengesellschaft FI Invests $982,000 in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 25,417 shares of the biopharmaceutical…
Qsemble Capital Management LP Invests $2.88 Million in Royalty Pharma PLC $RPRX
Qsemble Capital Management LP acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 74,416…
Acutaas Chemicals: The specialty chemicals story the market is re-rating fast
The key question is this: Is Acutaas Chemicals building a durable specialty chemicals franchise with multiple long-term growth engines? Or is the market extrapolating too much, too quickly, from a handful of high-growth verticals Understanding what…
HRF alleges unchecked industrial effluent discharge in Anakapalli district
The Human Rights Forum (HRF) has alleged large-scale discharge of untreated and inadequately treated industrial effluents into water bodies in the Atchutapuram-Rambilli industrial corridor of Anakapalli district, and demanded immediate intervention…
Domestic drugmakers make a play for the innovation league
Barely two weeks apart, domestic drugmakers inked two major overseas transactions in the US. Sun Pharmaceuticals formalised an agreement for a $12 billion (₹1,14,000 crore) buy of Organon, whose product basket includes women's health and…
JASCAYD (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Not intended for UK and US audiences JASCAYD (nerandomilast) now approved by Japan's MHLW for the treatment of adults with idiopathic pulmonary fibrosis and adults with progressive pulmonary fibrosis Approval enables access to the first oral PDE4B…
Pharmaceutical lobbyists can pop the champagne: Minnesota 340B legislation fails to get House vote on Legislature's final day to pass bills
The pharmaceutical industry won. The hospital industry lost. After a lobbying fight for the ages between the Pharmaceutical Researchers and Manufacturers of America and the Minnesota Hospital Association over a mysterious prescription drug discount…
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth (NASDAQ:SBRA)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Opinion: Our union supports Troy Jackson because we're long overdue for a governor who centers working people
The BDN Opinion section operates independently and does not set news policies or contribute to reporting or editing articles elsewhere in the newspaper or on bangordailynews.com Mark Brunton of Lewiston is president of the Maine Service Employees…
Lifesci Capital Predicts Lower Earnings for Opus Genetics
5 Space Stocks That Could Soar in the Next Decade Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Research analysts at Lifesci Capital decreased their Q3 2026 earnings estimates for Opus Genetics in a research note issued on Wednesday, May 13th.
Buzzing stocks: PFC-REC merger, RBL Bank deal, Adani Ports acquisition drive action
UK-based Prudential plc will acquire a majority 75 per cent stake in Bharti Life Insurance for Rs 3,500 crore from Bharti Life Ventures Pvt Ltd and 360 ONE Asset Management. Currently, Prudential is a partner with ICICI Bank, holding around a 22…
Receive a Daily briefing on Pharma Industry News
Get Started